Boston Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-10,373
| Closed | -$95K | – | 707 |
|
|
2015
Q4 | $95K | Sell |
10,373
-2,560
| -20% | -$23.4K | ﹤0.01% | 645 |
|
|
2015
Q3 | $90K | Sell |
12,933
-69,815
| -84% | -$486K | ﹤0.01% | 748 |
|
|
2015
Q2 | $813K | Buy |
82,748
+32,700
| +65% | +$321K | 0.03% | 325 |
|
|
2015
Q1 | $443K | Sell |
50,048
-5,013
| -9% | -$44.4K | 0.02% | 496 |
|
|
2014
Q4 | $482K | Hold |
55,061
| – | – | 0.02% | 348 |
|
|
2014
Q3 | $379K | Hold |
55,061
| – | – | 0.02% | 396 |
|
|
2014
Q2 | $290K | Buy |
55,061
+13,691
| +33% | +$72.1K | 0.01% | 491 |
|
|
2014
Q1 | $188K | Sell |
41,370
-830
| -2% | -$3.77K | 0.01% | 560 |
|
|
2013
Q4 | $213K | Buy |
42,200
+7,500
| +22% | +$37.9K | 0.01% | 554 |
|
|
2013
Q3 | $176K | Buy |
34,700
+11,900
| +52% | +$60.4K | 0.01% | 543 |
|
|
2013
Q2 | $113K | Buy |
+22,800
| New | +$113K | 0.01% | 552 |
|